Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.29 CAD | +20.83% | +31.82% | +31.82% |
May. 17 | NexgenRx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 16 | Charles Burns Tenders Resignation as Director of NexgenRx Inc | CI |
Business Summary
Number of employees: 20
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Administration Fees
45.9
%
| 5 | 35.6 % | 6 | 45.9 % | +39.72% |
Transaction Fees
37.4
%
| 6 | 50.2 % | 5 | 37.4 % | -19.32% |
Consulting
12.1
%
| 2 | 11.9 % | 2 | 12.1 % | +9.71% |
Other
4.0
%
| 0 | 1.6 % | 1 | 4.0 % | +169.38% |
Commission
0.6
%
| 0 | 0.7 % | 0 | 0.6 % | -4.75% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 13 | 100.0 % | 14 | 100.0 % | +8.33% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 03-03-12 | |
Director of Finance/CFO | 61 | 16-12-04 | |
Jason Robinson
ADM | Chief Administrative Officer | - | 17-12-31 |
Mark Payne
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-23 |
Andrew Munroe
COO | Chief Operating Officer | - | 17-01-31 |
Paul Freedman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Doreen Harvey
HRO | Human Resources Officer | - | - |
Avik Debroy
AUD | Comptroller/Controller/Auditor | - | - |
Corporate Secretary | - | 21-06-10 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 03-03-12 | |
Chairman | - | 06-03-06 | |
Charles Burns
BRD | Director/Board Member | - | 17-06-15 |
Randy E. McGlynn
BRD | Director/Board Member | - | 18-08-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 70,921,820 | 44,907,032 ( 63.32 %) | 0 | 63.32 % |
Stock B | 0 | 6,600,000 | 0 | 0 |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+31.82% | 15.04M | |
-1.50% | 119B | |
+6.90% | 96.87B | |
+14.19% | 68.75B | |
+21.20% | 64.78B | |
+13.29% | 44.1B | |
+15.31% | 43.5B | |
+20.57% | 35.57B | |
+9.28% | 26.28B | |
-1.25% | 23.04B |
- Stock Market
- Equities
- NXG Stock
- Company NexgenRx Inc.